The Effects of the Changes in the Special Reimbursement Rate of Type 2 Diabetes Medicines on the Use of Diabetes Medicines and Take-Up of Social Assistance
In the beginning of 2017, the special reimbursement rate of Type 2 diabetes medicines was lowered from the higher special reimbursement category with a reimbursement rate of 100% to the lower special reimbursement category with a reimbursement rate of 65%. This study examines how changing the reimbursement category of diabetes medicines has affected the use of medicines among individuals with Type 2 diabetes. In addition, we study the trends in the share of medicine costs covered by social assistance among those with Type 2 diabetes following the 2017 reform and compare them to the trends seen in social-assistance-supported medicine purchases among suitable control populations. The study uses Kela’s register data from 2010–2022.
Researchers
- Hanna Rättö, Leading Researcher
- Katri Aaltonen
- Terhi Kurko
Project Implementation Period
1.10.2017–31.12.2023. The project has ended.
